Special Populations
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 127 Shown
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017 1 comment / Last Comment: 6/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • Adopting Lung Cancer Screening Recommendations for an HIV-Infected Individual With a Smoking History

    David A. Wohl MD - 5/31/2017
    What qualifies an HIV-infected past or current smoker for annual lung cancer screening using low-dose CT scans?
  • ART Switch for Comorbidities in a Middle-Aged Black Woman

    Lisa Hightow-Weidman MD, MPH - 5/12/2017 1 comment / Last Comment: 6/16/2017
    One-tablet regimens may not always be the best choice of ART, but the best choice is always the one the patient is willing to take.
  • Initiating ART in a Hispanic MSM With Fear of Stigma and History of Depression

    Lisa Hightow-Weidman MD, MPH - 5/12/2017
    Understanding a patient’s life circumstances may be as important as any other aspect of providing good care.
  • Optimizing HIV Care Engagement for a Newly Diagnosed Young Black Man

    Lisa Hightow-Weidman MD, MPH - 5/12/2017
    In some cases, gaining trust may be the most important aspect of a patient’s care.
  • Contemporary Management of HIV: Best Practices for ART Management and Optimizing Outcomes in Persons of Color

    In this downloadable slideset, Lisa Hightow-Weidman, MD, MPH, and Program Director Eric S. Daar, MD, review key data and offer evidence-based guidance on linking and retaining persons of color in HIV care.
    Date Posted: 5/9/2017
  • Video Module cme-icon ce-icon

    Panel Discussion of Challenging Patient Cases in HIV

    Led by Kathleen E. Squires, MD, a panel of experts discusses their approach to management and prevention of HIV infection in complex clinical scenarios.
    Faculty: Joseph J. Eron, Jr. MD, Monica Gandhi MD, MPH, W. David Hardy MD, Kathleen E. Squires MD
    Released: 5/1/2017
  • Learning Module cme-icon ce-icon

    CCO Independent Conference Coverage: Clinical Impact of New Data From CROI 2017

    In this Expert Analysis, Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, provide an in-depth discussion of the most clinically relevant new data on the management of patients with HIV infection presented at CROI 2017.
    Faculty: Joel E. Gallant MD, MPH, Charles B. Hicks MD
    Released: 4/27/2017
  • Contemporary Management of HIV: New Data From CROI 2017

    In this downloadable slideset, Charles B. Hicks, MD, and Program Director Joseph J. Eron, Jr., MD, review key new HIV data presented at the Seattle 2017 meeting.

    Topics include:
    -Prevention
    -New data on currently available ART
    -Switch/simplification strategies for virologically suppressed patients
    -Investigational ARV agents
    -Treatment complications and comorbidities
    Date Posted: 4/26/2017
10 of 127 Shown
Show 10 More
Loading...